SEC Form 4 · accession 0001127602-15-003043
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas F Ackerman
Officer — Corp. Executive VP & CFO
Period of report
Jan 26, 2015
Accepted (ET)
Jan 28, 2015 · 2:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 26, 2015 | M | 10,000 | $37.92 | A | 114,211 | D | |
| Common Stock | Jan 26, 2015 | S | 10,000 | $70.00 | D | 104,211 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $37.92 | Jan 26, 2015 | M | 10,000 | D | Feb 26, 2011 | Feb 26, 2017 | Common Stock | 10,000 | 15,000 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.